Literature DB >> 16892183

From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation.

V Soumelis1, Y-J Liu.   

Abstract

Plasmacytoid dendritic cell precursors (pDC/IPC) are the major producers of type I interferon and have the unique ability to link innate and adaptive immunity. After producing large amounts of type I IFN in response to microbial stimulation, they can differentiate into DC capable of stimulating naive T cells and modulate the adaptive immune response. In this review, we focus on the transition between these two highly specialized cell types, which is accompanied by major morphological, structural and functional changes, many of which remain to be fully characterized. We propose that the plasmacytoid and dendritic morphologies correspond to distinct differentiation states and effector functions.

Mesh:

Substances:

Year:  2006        PMID: 16892183     DOI: 10.1002/eji.200636026

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  40 in total

Review 1.  Exploiting dendritic cells for active immunotherapy of cancer and chronic infections.

Authors:  David W O'Neill; Nina Bhardwaj
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

Review 2.  Understanding the multiple functions of Gr-1(+) cell subpopulations during microbial infection.

Authors:  Charlotte E Egan; Woraporn Sukhumavasi; Allison L Bierly; Eric Y Denkers
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes.

Authors:  Scott M J Cornwall; Matthew Wikstrom; Arthur W Musk; John Alvarez; Anna K Nowak; Delia J Nelson
Journal:  Oncoimmunology       Date:  2015-08-31       Impact factor: 8.110

Review 4.  Plasmacytoid dendritic cells of the gut: relevance to immunity and pathology.

Authors:  Vincent C Lombardi; Svetlana F Khaiboullina
Journal:  Clin Immunol       Date:  2014-04-24       Impact factor: 3.969

Review 5.  Dendritic cell-based vaccines: barriers and opportunities.

Authors:  Jessica A Cintolo; Jashodeep Datta; Sarah J Mathew; Brian J Czerniecki
Journal:  Future Oncol       Date:  2012-10       Impact factor: 3.404

6.  Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition.

Authors:  M R Sapienza; F Fuligni; C Agostinelli; C Tripodo; S Righi; M A Laginestra; A Pileri; M Mancini; M Rossi; F Ricci; A Gazzola; F Melle; C Mannu; F Ulbar; M Arpinati; M Paulli; T Maeda; D Gibellini; L Pagano; N Pimpinelli; M Santucci; L Cerroni; C M Croce; F Facchetti; P P Piccaluga; S A Pileri
Journal:  Leukemia       Date:  2014-02-07       Impact factor: 11.528

Review 7.  Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

8.  Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection.

Authors:  Allison L Bierly; William J Shufesky; Woraporn Sukhumavasi; Adrian E Morelli; Eric Y Denkers
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

9.  A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C.

Authors:  N A Libri; S J Barker; W M C Rosenberg; A E Semper
Journal:  J Viral Hepat       Date:  2009-02-24       Impact factor: 3.728

10.  Modulation of cytokine expression in human myeloid dendritic cells by environmental endocrine-disrupting chemicals involves epigenetic regulation.

Authors:  Chih-Hsing Hung; San-Nan Yang; Po-Lin Kuo; Yu-Te Chu; Hui-Wen Chang; Wan-Ju Wei; Shau-Ku Huang; Yuh-Jyh Jong
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.